Answers are grounded in this paper and cite their sources.
A prediction model estimates ctDNA detectability in advanced pancreatic cancer, suggesting improved testing strategies.
This prediction model enables accurate pre-test estimation of ctDNA detectability in advanced pancreatic cancer and may enhance the clinical utility of liquid CGP by informing optimal test selection and timing.
No takes yet. Share an insight, caveat, or question.
Ikushima et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: